Coffee consumption and risk of breast cancer: A Mendelian randomization study. 2021

Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Observational studies have reported either null or weak protective associations for coffee consumption and risk of breast cancer. We conducted a two-sample Mendelian randomization (MR) analysis to evaluate the relationship between coffee consumption and breast cancer risk using 33 single-nucleotide polymorphisms (SNPs) associated with coffee consumption from a genome-wide association (GWA) study on 212,119 female UK Biobank participants of White British ancestry. Risk estimates for breast cancer were retrieved from publicly available GWA summary statistics from the Breast Cancer Association Consortium (BCAC) on 122,977 cases (of which 69,501 were estrogen receptor (ER)-positive, 21,468 ER-negative) and 105,974 controls of European ancestry. Random-effects inverse variance weighted (IVW) MR analyses were performed along with several sensitivity analyses to assess the impact of potential MR assumption violations. One cup per day increase in genetically predicted coffee consumption in women was not associated with risk of total (IVW random-effects; odds ratio (OR): 0.91, 95% confidence intervals (CI): 0.80-1.02, P: 0.12, P for instrument heterogeneity: 7.17e-13), ER-positive (OR = 0.90, 95% CI: 0.79-1.02, P: 0.09) and ER-negative breast cancer (OR: 0.88, 95% CI: 0.75-1.03, P: 0.12). Null associations were also found in the sensitivity analyses using MR-Egger (total breast cancer; OR: 1.00, 95% CI: 0.80-1.25), weighted median (OR: 0.97, 95% CI: 0.89-1.05) and weighted mode (OR: 1.00, CI: 0.93-1.07). The results of this large MR study do not support an association of genetically predicted coffee consumption on breast cancer risk, but we cannot rule out existence of a weak association.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003069 Coffee A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios
D016208 Databases, Factual Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references. Databanks, Factual,Data Banks, Factual,Data Bases, Factual,Data Bank, Factual,Data Base, Factual,Databank, Factual,Database, Factual,Factual Data Bank,Factual Data Banks,Factual Data Base,Factual Data Bases,Factual Databank,Factual Databanks,Factual Database,Factual Databases

Related Publications

Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
April 2020, Annals of neurology,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
September 2023, Genes & nutrition,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
April 2018, International journal of epidemiology,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
May 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
June 2021, Nutrients,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
January 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
July 2020, Cancer genetics,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
October 2022, Clinical nutrition (Edinburgh, Scotland),
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
January 2022, Frontiers in nutrition,
Merete Ellingjord-Dale, and Nikos Papadimitriou, and Michail Katsoulis, and Chew Yee, and Niki Dimou, and Dipender Gill, and Dagfinn Aune, and Jue-Sheng Ong, and Stuart MacGregor, and Benjamin Elsworth, and Sarah J Lewis, and Richard M Martin, and Elio Riboli, and Konstantinos K Tsilidis
November 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Copied contents to your clipboard!